Cargando…
Preliminary Study to Evaluate Three Different Treatments on Stable Chronic Obstructive Pulmonary Disease Patients Based on Markov Model
This study evaluates the costs and utilities of different treatment strategies for stable chronic obstructive pulmonary disease (COPD) patients based on Markov model and provides guidance for clinical decision and health policy making. Patients with stable COPD from four subcenters had been investig...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6500607/ https://www.ncbi.nlm.nih.gov/pubmed/31118965 http://dx.doi.org/10.1155/2019/6478926 |
_version_ | 1783415978938335232 |
---|---|
author | Yu, Xue-qing Yang, Shu-guang Li, Han Xie, Yang Li, Jian-sheng Zhang, Pan |
author_facet | Yu, Xue-qing Yang, Shu-guang Li, Han Xie, Yang Li, Jian-sheng Zhang, Pan |
author_sort | Yu, Xue-qing |
collection | PubMed |
description | This study evaluates the costs and utilities of different treatment strategies for stable chronic obstructive pulmonary disease (COPD) patients based on Markov model and provides guidance for clinical decision and health policy making. Patients with stable COPD from four subcenters had been investigated. A Markov model with three states, namely, GOLD 1-2, GOLD 3-4, and death, was built using TreeAge Pro 2011 software. Cost-utility ratio (CUR) and incremental cost-utility ratio (ICUR) from forty Markov circles were applied to measuring the economics evaluation of three different treatments. A total of 236 stable COPD patients were randomly assigned into three groups, Western medicine group (79 cases), traditional Chinese medicine (TCM) group (79 cases), and combined group (78 cases). The results of Markov cohort simulation showed that the accumulative quality-adjusted life years (QALYs) of the three above groups per 100 000 people in 40 years were 1 702 773, 1 616 797, and 1 709 668 years, respectively, and the accumulative costs were 13 582 138 466, 1 207 904 113, and 14 656 607 371 Yuan, respectively. The CURs of the three groups were 87 235, 74 602, and 87 223 Yuan/QALY, respectively. ICURs of combined group were 8 707 and 41 705 Yuan as against Western medicine group and TCM group, respectively. Therefore, combined treatment has a lower cost, higher health output, and more socioeconomic benefits in the long run. Markov model is recommended to conduct health economics evaluation of different treatments for COPD. |
format | Online Article Text |
id | pubmed-6500607 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | Hindawi |
record_format | MEDLINE/PubMed |
spelling | pubmed-65006072019-05-22 Preliminary Study to Evaluate Three Different Treatments on Stable Chronic Obstructive Pulmonary Disease Patients Based on Markov Model Yu, Xue-qing Yang, Shu-guang Li, Han Xie, Yang Li, Jian-sheng Zhang, Pan Evid Based Complement Alternat Med Research Article This study evaluates the costs and utilities of different treatment strategies for stable chronic obstructive pulmonary disease (COPD) patients based on Markov model and provides guidance for clinical decision and health policy making. Patients with stable COPD from four subcenters had been investigated. A Markov model with three states, namely, GOLD 1-2, GOLD 3-4, and death, was built using TreeAge Pro 2011 software. Cost-utility ratio (CUR) and incremental cost-utility ratio (ICUR) from forty Markov circles were applied to measuring the economics evaluation of three different treatments. A total of 236 stable COPD patients were randomly assigned into three groups, Western medicine group (79 cases), traditional Chinese medicine (TCM) group (79 cases), and combined group (78 cases). The results of Markov cohort simulation showed that the accumulative quality-adjusted life years (QALYs) of the three above groups per 100 000 people in 40 years were 1 702 773, 1 616 797, and 1 709 668 years, respectively, and the accumulative costs were 13 582 138 466, 1 207 904 113, and 14 656 607 371 Yuan, respectively. The CURs of the three groups were 87 235, 74 602, and 87 223 Yuan/QALY, respectively. ICURs of combined group were 8 707 and 41 705 Yuan as against Western medicine group and TCM group, respectively. Therefore, combined treatment has a lower cost, higher health output, and more socioeconomic benefits in the long run. Markov model is recommended to conduct health economics evaluation of different treatments for COPD. Hindawi 2019-04-17 /pmc/articles/PMC6500607/ /pubmed/31118965 http://dx.doi.org/10.1155/2019/6478926 Text en Copyright © 2019 Xue-qing Yu et al. https://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research Article Yu, Xue-qing Yang, Shu-guang Li, Han Xie, Yang Li, Jian-sheng Zhang, Pan Preliminary Study to Evaluate Three Different Treatments on Stable Chronic Obstructive Pulmonary Disease Patients Based on Markov Model |
title | Preliminary Study to Evaluate Three Different Treatments on Stable Chronic Obstructive Pulmonary Disease Patients Based on Markov Model |
title_full | Preliminary Study to Evaluate Three Different Treatments on Stable Chronic Obstructive Pulmonary Disease Patients Based on Markov Model |
title_fullStr | Preliminary Study to Evaluate Three Different Treatments on Stable Chronic Obstructive Pulmonary Disease Patients Based on Markov Model |
title_full_unstemmed | Preliminary Study to Evaluate Three Different Treatments on Stable Chronic Obstructive Pulmonary Disease Patients Based on Markov Model |
title_short | Preliminary Study to Evaluate Three Different Treatments on Stable Chronic Obstructive Pulmonary Disease Patients Based on Markov Model |
title_sort | preliminary study to evaluate three different treatments on stable chronic obstructive pulmonary disease patients based on markov model |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6500607/ https://www.ncbi.nlm.nih.gov/pubmed/31118965 http://dx.doi.org/10.1155/2019/6478926 |
work_keys_str_mv | AT yuxueqing preliminarystudytoevaluatethreedifferenttreatmentsonstablechronicobstructivepulmonarydiseasepatientsbasedonmarkovmodel AT yangshuguang preliminarystudytoevaluatethreedifferenttreatmentsonstablechronicobstructivepulmonarydiseasepatientsbasedonmarkovmodel AT lihan preliminarystudytoevaluatethreedifferenttreatmentsonstablechronicobstructivepulmonarydiseasepatientsbasedonmarkovmodel AT xieyang preliminarystudytoevaluatethreedifferenttreatmentsonstablechronicobstructivepulmonarydiseasepatientsbasedonmarkovmodel AT lijiansheng preliminarystudytoevaluatethreedifferenttreatmentsonstablechronicobstructivepulmonarydiseasepatientsbasedonmarkovmodel AT zhangpan preliminarystudytoevaluatethreedifferenttreatmentsonstablechronicobstructivepulmonarydiseasepatientsbasedonmarkovmodel |